2017 annual financial data
Innate Pharma 2017 Operating margin
Direct answer
Operating margin was -122.53%.
Operating income was -39,983,000 EUR and net income was -48,385,000 EUR.
Operating cash flow was Not available.
Get free Innate Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 32,631,000 EUR
- Operating income
- -39,983,000 EUR
- Net income
- -48,385,000 EUR
- Operating cash flow
- Not available